These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 29220347)

  • 1. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the impact of biannual school-based and community-wide treatment on urogenital schistosomiasis in Niger.
    Phillips AE; Tohon Z; Dhanani NA; Sofo B; Gnandou I; Sidikou B; Noma AG; Madougou B; Alto O; Sebangou H; Halilou KM; Andia R; Garba A; Fenwick A; Hamidou AA
    Parasit Vectors; 2020 Nov; 13(1):557. PubMed ID: 33203477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urogenital schistosomiasis in Cabo Delgado, northern Mozambique: baseline findings from the SCORE study.
    Phillips AE; Gazzinelli-Guimarães PH; Aurelio HO; Dhanani N; Ferro J; Nala R; Deol A; Fenwick A
    Parasit Vectors; 2018 Jan; 11(1):30. PubMed ID: 29316983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey.
    Knopp S; Person B; Ame SM; Ali SM; Muhsin J; Juma S; Khamis IS; Rabone M; Blair L; Fenwick A; Mohammed KA; Rollinson D
    Parasit Vectors; 2016 Jan; 9():5. PubMed ID: 26727915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrupting seasonal transmission of Schistosoma haematobium and control of soil-transmitted helminthiasis in northern and central Côte d'Ivoire: a SCORE study protocol.
    Tian-Bi YT; Ouattara M; Knopp S; Coulibaly JT; Hürlimann E; Webster B; Allan F; Rollinson D; Meïté A; Diakité NR; Konan CK; N'Goran EK; Utzinger J
    BMC Public Health; 2018 Jan; 18(1):186. PubMed ID: 29378542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of integrated interventions layered on mass drug administration for urogenital schistosomiasis elimination: a cluster-randomised trial.
    Knopp S; Person B; Ame SM; Ali SM; Hattendorf J; Juma S; Muhsin J; Khamis IS; Mohammed KA; Utzinger J; Hollenberg E; Kabole F; Rollinson D
    Lancet Glob Health; 2019 Aug; 7(8):e1118-e1129. PubMed ID: 31255591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA; Momo SC; Stothard JR; Rollinson D
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of praziquantel against urinary schistosomiasis and reinfection in Senegalese school children where there is a single well-defined transmission period.
    Senghor B; Diaw OT; Doucoure S; Sylla SN; Seye M; Talla I; Bâ CT; Diallo A; Sokhna C
    Parasit Vectors; 2015 Jul; 8():362. PubMed ID: 26156522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year impact of single praziquantel treatment on infection in the national control programme on schistosomiasis in Burkina Faso.
    Touré S; Zhang Y; Bosqué-Oliva E; Ky C; Ouedraogo A; Koukounari A; Gabrielli AF; Bertrand S; Webster JP; Fenwick A
    Bull World Health Organ; 2008 Oct; 86(10):780-7, A. PubMed ID: 18949215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
    Shen Y; King CH; Binder S; Zhang F; Whalen CC; Evan Secor W; Montgomery SP; Mwinzi PNM; Olsen A; Magnussen P; Kinung'hi S; Phillips AE; Nalá R; Ferro J; Aurelio HO; Fleming F; Garba A; Hamidou A; Fenwick A; Campbell CH; Colley DG
    BMC Infect Dis; 2017 Sep; 17(1):652. PubMed ID: 28962552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity.
    Chisango TJ; Ndlovu B; Vengesai A; Nhidza AF; Sibanda EP; Zhou D; Mutapi F; Mduluza T
    BMC Infect Dis; 2019 Mar; 19(1):219. PubMed ID: 30832614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy.
    Ouedraogo H; Drabo F; Zongo D; Bagayan M; Bamba I; Pima T; Yago-Wienne F; Toubali E; Zhang Y
    Bull World Health Organ; 2016 Jan; 94(1):37-45. PubMed ID: 26769995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of persistent hotspots of Schistosoma mansoni in western Côte d'Ivoire.
    Assaré RK; N'Tamon RN; Bellai LG; Koffi JA; Mathieu TI; Ouattara M; Hürlimann E; Coulibaly JT; Diabaté S; N'Goran EK; Utzinger J
    Parasit Vectors; 2020 Jul; 13(1):337. PubMed ID: 32616074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment.
    Landouré A; Dembélé R; Goita S; Kané M; Tuinsma M; Sacko M; Toubali E; French MD; Keita AD; Fenwick A; Traoré MS; Zhang Y
    PLoS Negl Trop Dis; 2012; 6(7):e1774. PubMed ID: 22860153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5-Year intervention study on elimination of urogenital schistosomiasis in Zanzibar: Parasitological results of annual cross-sectional surveys.
    Knopp S; Ame SM; Person B; Hattendorf J; Rabone M; Juma S; Muhsin J; Khamis IS; Hollenberg E; Mohammed KA; Kabole F; Ali SM; Rollinson D
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007268. PubMed ID: 31059495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a Seasonal Transmission Focus in Central Senegal.
    Senghor B; Diaw OT; Doucoure S; Seye M; Diallo A; Talla I; Bâ CT; Sokhna C
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004557. PubMed ID: 27015646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
    Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial
    Secor WE; Wiegand RE; Montgomery SP; Karanja DMS; Odiere MR
    Am J Trop Med Hyg; 2020 Feb; 102(2):318-327. PubMed ID: 31802733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.